Mobia Medical to Report Second Quarter 2026 Financial Results on August 11, 2026
Rhea-AI Summary
Mobia Medical (Nasdaq: MOBI) announced it will report its second quarter 2026 financial results on Tuesday, August 11, 2026. Management will host a conference call and webcast at 4:30 p.m. ET the same day to review results and provide a corporate update. Investors must register online in advance to receive dial-in details and a unique PIN, while a live and archived webcast will be available on the News & Events page of the company’s investor website.
Positive
- None.
Negative
- None.
Market reaction after 2Q26 earnings report: MOBI -7.76% in the Jul 22 session
In the Jul 22 session, MOBI declined 7.76%, reflecting a notable negative market reaction. Argus tracked a trough of -4.3% from its starting point during tracking. Our momentum scanner triggered 6 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jul 14 | Clinical data publication | Positive | +2.2% | Two-year VNS-REHAB data showed durable stroke recovery and no long-term serious therapy-related events. |
| Jul 02 | Reimbursement update | Positive | -2.9% | CMS proposed maintaining Vivistim's New Technology APC placement and estimated hospital outpatient payment. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Mobia's recent positive announcements produced mixed market alignment, with one positive reaction and one divergence.
AI-generated analysis. How Rhea-AI works. Not financial advice.
AUSTIN, Texas, July 21, 2026 (GLOBE NEWSWIRE) -- Mobia Medical, Inc. (Nasdaq: MOBI), a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today announced that the Company will report second quarter 2026 financial results on Tuesday, August 11, 2026. Mobia Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
Those interested in listening to the conference call should register online using this link. Once registered, participants will receive dial-in numbers and a unique PIN to join the call. Participants are encouraged to register more than 15 minutes prior to the start of the call. A live and archived webcast can also be accessed via the News & Events page of the investor section of Mobia Medical’s website.
About Mobia Medical, Inc.
Mobia Medical, Inc. is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company’s Vivistim® Paired VNS™ System is the first and only clinically validated, FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Therapy with the Vivistim® Paired VNS™ System combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. Mobia Medical is mobilizing patients, providers, and care partners to establish a better way forward in stroke care.
Investor Relations Contact
Louisa Smith
Gilmartin Group, LLC
investors@mobia.com
